Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition).
Betacoronavirus
/ pathogenicity
COVID-19
Consensus
Coronavirus Infections
/ diagnosis
Critical Illness
Cross Infection
/ diagnosis
Host-Pathogen Interactions
Humans
Infection Control
/ standards
Infectious Disease Transmission, Patient-to-Professional
/ prevention & control
Intensive Care Units
/ standards
Nervous System Diseases
/ diagnosis
Neurology
/ standards
Occupational Health
Pandemics
/ prevention & control
Patient Safety
Pneumonia, Viral
/ diagnosis
Risk Assessment
Risk Factors
SARS-CoV-2
Treatment Outcome
infection
Journal
Stroke and vascular neurology
ISSN: 2059-8696
Titre abrégé: Stroke Vasc Neurol
Pays: England
ID NLM: 101689996
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
received:
27
04
2020
revised:
04
06
2020
accepted:
06
06
2020
pubmed:
10
7
2020
medline:
8
10
2020
entrez:
10
7
2020
Statut:
ppublish
Résumé
During the COVID-19 epidemic, the treatment of critically ill patients has been increasingly difficult and challenging. During the epidemic, some patients with neurological diseases also have COVID-19, which could be misdiagnosed and cause silent transmission and nosocomial infection. Such risk is high in a neurological intensive care unit (NCU). Therefore, prevention and control of epidemic in critically ill patients is of utmost importance. The principle of NCU care should include comprehensive screening and risk assessment, weighing risk against benefits and reducing the risk of COVID-19 transmission while treating patients as promptly as possible.
Identifiants
pubmed: 32641446
pii: svn-2020-000409
doi: 10.1136/svn-2020-000409
pmc: PMC7548511
doi:
Types de publication
Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
242-249Informations de copyright
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
JAMA. 2020 Mar 17;323(11):1061-1069
pubmed: 32031570
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
Clin Infect Dis. 2005 Oct 15;41(8):1089-96
pubmed: 16163626
J Pathol. 2004 Jun;203(2):631-7
pubmed: 15141377
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104941
pubmed: 32689643
N Engl J Med. 2020 Jun 11;382(24):2327-2336
pubmed: 32275812
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Emerg Infect Dis. 2004 Feb;10(2):342-4
pubmed: 15030709